News & Events RSS Feed

14 February 2014

Interim Results Statement for the six month period ended 31 December 2013

The Board of Physiomics today announces its interim financial results for the six months ended 31 December 2013. Read more.

16 January 2014

Physiomics to collaborate with the University of Dundee to “optimize drug design and testing” with grant support from the Northern Research Partnership

Physiomics plc is pleased to announce that it has signed a collaboration agreement with the University of Dundee. Physiomics part of the collaboration will be fully funded by the Northern Research Partnership (“NRP”) in the form of an “Early Career Researcher Engagement and Exchanges with Business & Industry” agreement. Read more.

4 December 2013

New Agreement to advance inhibitor of novel target with global pharma company

Physiomics is pleased to announce that it has signed a substantial new contract with a major global pharmaceutical company. The programme of studies will begin immediately and take an estimated 9 months to reach a conclusion. Physiomics will determine the optimal dosing regimen of a new compound currently under development by this client. Read more.

28 November 2013

Physiomics launches new DrugCARD® database for oncology researchers and clinicians

Physiomics is pleased to announce that it has now launched its Drug Combinations and Regimens database. DrugCARD® collates curated publicly available pre-clinical and clinical drug regimen data into one easily searchable tool. It also contains further clinical data and analysis which is only available through the collaboration with Pharmacometrics. Read more.

28 November 2013

Physiomics is recruiting: Biosimulation Scientist

We have an opportunity for a Biosimulation Scientist to join our technical team to work on projects related to drug development. Find more details at our careers page.

11 November 2013

Physiomics to collaborate with the University of Oxford and the Oxford University Hospitals NHS trust on its Virtual Tumour Clinical research program

Physiomics is pleased to announce that it has signed a collaboration agreement with the University of Oxford and the Oxford University Hospitals NHS trust to support the development of Physiomics’ flagship Virtual Tumour Clinical technology. Virtual Tumour Clinical is used to predict optimal clinical regimens for cancer trials. Physiomics has been seeking academic and industrial […]

4 November 2013

Physiomics to update on the Virtual Tumour Clinical platform at the 2013 NCRI Cancer Conference

Physiomics is pleased to announce that it is participating in the 2013 NCRI Cancer Conference, taking place at the BT Convention Centre, Liverpool, on 3-6 November 2013. Dr Eric Fernandez, Project Leader, will present details of the on-going development of the Virtual Tumour Clinical platform. The abstract ("Dosing and schedule optimization with Virtual Tumour Clinical […]

Page 3 of 1612345...10...Last